Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial-Reference-Cited by-同舟云学术

Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial

Published:2019-07 Issue:7 Volume:6 Page:e428-e437
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Venter Willem D F,Moorhouse Michelle,Sokhela Simiso,Serenata Celicia,Akpomiemie Godspower,Qavi Ambar,Mashabane Nonkululeko,Arulappan Natasha,Sim Joel W,Sinxadi Phumla Z,Wiesner Lubbe,Maharaj Ellisha,Wallis Carole,Boyles Tom,Ripin David,Stacey Sarah,Chitauri Gila,Hill Andrew

Funder

National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference21 articles.

1. The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?;Vitoria;AIDS,2018

2. Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial;Orkin;HIV Med,2013

3. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomized, controlled phase III trial;Madruga;Lancet,2007

4. Efficacy and tolerability of 3 non-nucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial;Lennox;Ann Intern Med,2014

5. Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1;Katlama;AIDS,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion of pregnant and breastfeeding women in nonobstetrical randomized controlled trials;American Journal of Obstetrics & Gynecology MFM;2022-11

2. Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes;Journal of Molecular Structure;2022-10

3. Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa;BMC Infectious Diseases;2022-05-12

4. Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective;AIDS;2021-12-15

5. Predictors of impaired pulmonary function in people living with HIV in an urban African setting;Southern African Journal of HIV Medicine;2021-08-17